These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18811715)

  • 21. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres.
    Roy D; Sadick N; Mangat D
    Dermatol Surg; 2006 Sep; 32(9):1134-9. PubMed ID: 16970693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence.
    Mayer RD; Dmochowski RR; Appell RA; Sand PK; Klimberg IW; Jacoby K; Graham CW; Snyder JA; Nitti VW; Winters JC
    Urology; 2007 May; 69(5):876-80. PubMed ID: 17482925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.
    Marmur E; Green L; Busso M
    Dermatol Surg; 2010 Mar; 36(3):309-15. PubMed ID: 20100272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone.
    Orentreich D; Leone AS
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):548-51. PubMed ID: 15056149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
    Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
    AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician and patient satisfaction after use of calcium hydroxylapatite for cheek augmentation.
    Moers-Carpi M; Storck R; Howell DJ; Ogilvie P; Ogilvie A
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1217-22. PubMed ID: 22759259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report.
    Rosen CA; Gartner-Schmidt J; Casiano R; Anderson TD; Johnson F; Remacle M; Sataloff RT; Abitbol J; Shaw G; Archer S; Zraick RI
    Laryngoscope; 2009 May; 119(5):1033-41. PubMed ID: 19274731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results.
    Bass LS; Smith S; Busso M; McClaren M
    Aesthet Surg J; 2010 Mar; 30(2):235-8. PubMed ID: 20442101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable calcium hydroxylapatite for correction of nasal bridge deformities.
    Siclovan HR; Jomah JA
    Aesthetic Plast Surg; 2009 Jul; 33(4):544-8. PubMed ID: 19067034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-associated facial lipoatrophy treated with injectable silicone oil: a pilot study.
    Chen F; Carruthers A; Humphrey S; Carruthers J
    J Am Acad Dermatol; 2013 Sep; 69(3):431-7. PubMed ID: 23711767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vocal fold augmentation with calcium hydroxylapatite (CaHA).
    Rosen CA; Gartner-Schmidt J; Casiano R; Anderson TD; Johnson F; Reussner L; Remacle M; Sataloff RT; Abitbol J; Shaw G; Archer S; McWhorter A
    Otolaryngol Head Neck Surg; 2007 Feb; 136(2):198-204. PubMed ID: 17275539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss.
    Muti GF
    J Drugs Dermatol; 2019 Jan; 18(1):86-91. PubMed ID: 30681803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lasting results with hydroxylapatite (Radiesse) facial filler.
    Jacovella PF; Peiretti CB; Cunille D; Salzamendi M; Schechtel SA
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):15S-21S. PubMed ID: 16936540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.
    Pignatti M; Pedone A; Baccarani A; Guaraldi G; Orlando G; Lombardi M; De Santis G
    Aesthetic Plast Surg; 2012 Feb; 36(1):180-5. PubMed ID: 21717261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of one-step rehabilitation of human immunodeficiency virus-related facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler.
    Rauso R; Curinga G; Rusciani A; Colella G; Amore R; Tartaro G
    Dermatol Surg; 2013 Dec; 39(12):1887-94. PubMed ID: 24299576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen.
    Lapatina NG; Pavlenko T
    J Drugs Dermatol; 2017 Sep; 16(9):900-906. PubMed ID: 28915285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler.
    Marmur ES; Phelps R; Goldberg DJ
    J Cosmet Laser Ther; 2004 Dec; 6(4):223-6. PubMed ID: 16020207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.